ArticleCancer research2015

CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.

Jemima Escamilla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.